Objective: To compare the safety and efficacy of myocardial contrast enhancement (MCE)-guided and angio-pressure (AP)-guided transcoronary ablation of septal hypertrophy (TASH) for patients with hypertrophic obstructive cardiomyopathy (HOCM).

Methods: TASH was performed under MCE-guide (n = 47, group I) or AP-guide (n = 25, group II) for drug-refractory patients with HOCM. Myocardial perfusion imaging (MPI) data as well as other clinical data were compared.

Results: TASH both under MCE-guide or AP-guide resulted in similar and significant reduction of left ventricular outflow tract gradient (PG) and associated with significant symptom improvement (all P < 0.001). Dosage of ethanol use, peak-level of CK-MB and ablated myocardial area and incidence of arrhythmia were also similar between the two groups.Similar left ventricular/atrial dimension changes post TASH were observed in the 2 groups during follow-up. However, the first selected septal vessels were changed under MCE in 6 patients.

Conclusions: Our data demonstrated that the MCE-guided TASH was not superior to AP-guided TASH in safety and efficacy. However, MCE-guided TASH can avoid the misplace of ethanol to avoid innocent myocardial ablation.

Download full-text PDF

Source

Publication Analysis

Top Keywords

myocardial contrast
8
transcoronary ablation
8
ablation septal
8
septal hypertrophy
8
patients hypertrophic
8
hypertrophic obstructive
8
safety efficacy
8
mce-guided tash
8
tash
7
myocardial
5

Similar Publications

Regional Image Quality Scoring for 2-D Echocardiography Using Deep Learning.

Ultrasound Med Biol

January 2025

Department of Circulation and Medical Imaging, Norwegian University of Science and Technology - NTNU, Trondheim, Norway; Health Research, SINTEF, Trondheim, Norway.

Objective: To develop and compare methods to automatically estimate regional ultrasound image quality for echocardiography separate from view correctness.

Methods: Three methods for estimating image quality were developed: (i) classic pixel-based metric: the generalized contrast-to-noise ratio (gCNR), computed on myocardial segments (region of interest) and left ventricle lumen (background), extracted by a U-Net segmentation model; (ii) local image coherence: the average local coherence as predicted by a U-Net model that predicts image coherence from B-mode ultrasound images at the pixel level; (iii) deep convolutional network: an end-to-end deep-learning model that predicts the quality of each region in the image directly. These methods were evaluated against manual regional quality annotations provided by three experienced cardiologists.

View Article and Find Full Text PDF

Data regarding cardiogenic shock (CS) from safety-net hospitals serving socioeconomically-disadvantaged patients are limited. In addition, little is known regarding long-term outcomes and management of heart failure-related CS (HF-CS), a population potentially especially vulnerable to adverse social determinants of health (SDOH). A single-center retrospective cohort study of patients with Stage C, D, or E CS at a public safety-net hospital between 2017-2023 was performed.

View Article and Find Full Text PDF

Background: Diabetes mellitus is associated with morphological and functional impairment of the heart primarily due to lipid toxicity caused by increased fatty acid metabolism. Extracellular signal-regulated protein kinases 1 and 2 (ERK1/2) have been implicated in the metabolism of fatty acids in the liver and skeletal muscles. However, their role in the heart in diabetes remains unclear.

View Article and Find Full Text PDF

Glucagon can increase the force of contraction (FOC) in, for example, canine hearts. Currently, whether glucagon can also increase the FOC via cAMP-increasing receptors in the human atrium is controversial discussed. Glucagon alone did not (up to 1 µM) raise the FOC in human right atrial preparations (HAP).

View Article and Find Full Text PDF

Since its first pathological description over 65 years ago, hypertrophic cardiomyopathy (HCM), with a worldwide prevalence of 1:500, has emerged as the most common genetically determined cardiac disease. Diagnostic work-up has dramatically improved over the last decades, from clinical suspicion and abnormal electrocardiographic findings to hemodynamic studies, echocardiography, contrast-enhanced cardiac magnetic resonance, and genetic testing. The implementation of screening programs and the use of implantable cardioverter defibrillators (ICDs) for high-risk individuals have notably reduced arrhythmic sudden deaths, altering the disease's mortality profile.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!